|
R&D Systems
biotinylated anti human ccl20 Biotinylated Anti Human Ccl20, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/BAF360/Human+CCL20%2FMIP-3+alpha+Biotinylated+Antibody/us10640564-1006-6-9 Average 90 stars, based on 1 article reviews
biotinylated anti human ccl20 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
R&D Systems
anti ccl20 biotinylated antibody Anti Ccl20 Biotinylated Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/BAF360/Human+CCL20%2FMIP-3+alpha+Biotinylated+Antibody/pm28552941-59-1-11 Average 90 stars, based on 1 article reviews
anti ccl20 biotinylated antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
R&D Systems
anti ccl20 antibody Anti Ccl20 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/BAF360/Human+CCL20%2FMIP-3+alpha+Biotinylated+Antibody/pm28552941-59-5-11 Average 90 stars, based on 1 article reviews
anti ccl20 antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
R&D Systems Hematology
ccl20 ![]() Ccl20, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/BAF360/Human+CCL20%2FMIP-3+alpha+Biotinylated+Antibody/pmc05446182-121-12-14 Average 86 stars, based on 1 article reviews
ccl20 - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
R&D Systems
anti human ccl20 ![]() Anti Human Ccl20, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/BAF360/Human+CCL20%2FMIP-3+alpha+Biotinylated+Antibody/pmc04035256-44-50-55 Average 90 stars, based on 1 article reviews
anti human ccl20 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
R&D Systems
goat anti human ccl20 ![]() Goat Anti Human Ccl20, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/BAF360/Human+CCL20%2FMIP-3+alpha+Biotinylated+Antibody/pmc03688882-76-41-46 Average 90 stars, based on 1 article reviews
goat anti human ccl20 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
R&D Systems
biotinylated goat anti human ccl20 ![]() Biotinylated Goat Anti Human Ccl20, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/BAF360/Human+CCL20%2FMIP-3+alpha+Biotinylated+Antibody/pm16709808-48-0-6 Average 90 stars, based on 1 article reviews
biotinylated goat anti human ccl20 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Journal: PLoS ONE
Article Title: CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy
doi: 10.1371/journal.pone.0178352
Figure Lengend Snippet: Primers used for real-time PCR.
Article Snippet: Some of the sections were stained with an antibody directed against the
Techniques: Sequencing
Journal: PLoS ONE
Article Title: CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy
doi: 10.1371/journal.pone.0178352
Figure Lengend Snippet: (A) mRNA expression level of CCL20(a) and protein level (b) in IgA1 (purified from IgAN patients serum (IgAN) or health control (HC))-treated HMC were evaluated by qRT-PCR (normalized by GAPDH) and ELISA. (B) Meanwhile TGF-beta expression level were also evaluated by qRT-PCR (normalized by GAPDH) (a) and ELISA (b) for IgA1-treated HMC. (C) CCL20 protein levels of serum from different classification of IgAN patients (HassI: n = 21, P = 0.045. HassII: n = 14, P = 0.0001. HassIII: n = 13, P = 0.0049) and HC peoples ( n = 41) were measured by ELISA. * P <0.05, ** P <0.01, *** P <0.001, ns: no significant difference. The data are representative of four independent experiments.
Article Snippet: Some of the sections were stained with an antibody directed against the
Techniques: Expressing, Purification, Control, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay
Journal: PLoS ONE
Article Title: CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy
doi: 10.1371/journal.pone.0178352
Figure Lengend Snippet: (A) The attracted cells by CCL20 were more CD3 + T cells analyzed by FACS. (B) The attracted T cells by CCL20 were more CCR6 + T cells analyzed by FACS. * P <0.05. The data are representative of three independent experiments.
Article Snippet: Some of the sections were stained with an antibody directed against the
Techniques:
Journal: PLoS ONE
Article Title: CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy
doi: 10.1371/journal.pone.0178352
Figure Lengend Snippet: CCL20 are detected by immunohistochemical staining for sections from non-IgAN nephrotic syndrome or IgAN patients.
Article Snippet: Some of the sections were stained with an antibody directed against the
Techniques: Immunohistochemical staining, Staining
Journal: PLoS ONE
Article Title: CCR6, the Sole Receptor for the Chemokine CCL20, Promotes Spontaneous Intestinal Tumorigenesis
doi: 10.1371/journal.pone.0097566
Figure Lengend Snippet: (A) CCL20 concentration was assayed by ELISA in 12 matched samples of colon cancer and adjacent normal colon tissue after homogenizing approximately 100 mg of tissue into 100 µl PBS. The Wilcoxon signed-rank test was used to assess significance. (B) Representative photomicrograph of a section of paraffin-embedded human colon cancer tumor tissue immunohistochemically stained for CCL20. The regions in the squares are shown magnified. (C) Relative expression of human Ccr6 is compared in 10 matched samples of colon cancer and adjacent uninvolved colon tissue as measured by semiquantitative RT-PCR. (D) Representative photomicrograph of a section of paraffin-embedded human colon cancer tumor tissue immunohistochemically stained for CCR6. The regions in the squares are shown magnified.
Article Snippet: The primary antibodies utilized were anti-mouse B220 (clone-RA3-6B2, BD Biosciences, San Jose, CA), anti-mouse CD3 (Clone-SP7, Abcam, Cambridge, MA), anti-mouse F4/80 (clone-A3-1, AbD Serotec US, Raleigh, NC), anti-mouse FoxP3, (clone- FJK-16, eBioscience, San Diego, CA), anti-human CD163 (clone-10D6, Vector Laboratories Burlingame, CA), anti-human CCR6 (clone- 53103, R&D Systems, Minneapolis, MN),
Techniques: Concentration Assay, Enzyme-linked Immunosorbent Assay, Staining, Expressing, Reverse Transcription Polymerase Chain Reaction
Journal: PLoS ONE
Article Title: CCR6, the Sole Receptor for the Chemokine CCL20, Promotes Spontaneous Intestinal Tumorigenesis
doi: 10.1371/journal.pone.0097566
Figure Lengend Snippet: (A) CCL20 concentrations in the ileum of APC MIN/+ and CCR6KO-APC MIN/+ mice at 15 weeks of age as measured by ELISA are shown. (Representative data from 1 of 2 experiments is shown.) (B) CCR6 expression is demonstrated in the murine colorectal cancer cell line MC38 both by Western blot analysis comparing cell lysates of MC38 cells, WT spleen, and CCR6KO spleen (left panel); and by immunofluorescence staining of cytospin specimens of MC38 cells (right panel). (C) CCL20-induced production of CCL20 was measured by exposing MC38 cells (left panel) as well as WT and CCR6KO splenocytes (right panel) to CCL20 at 50 ng/ml for 1 hour and analyzing culture supernatants 30, 60 and 90 minutes after withdrawal of CCL20. (Representative data from 1 of 3 experiments is shown.) (D) CCL20 was measured after exposing the human colon cancer cell lines HT29 (left panel) and Hct116 (right panel) to 50 ng/ml CCL20 for 1 hour and analyzing culture supernatants 30, 60 and 90 minutes after withdrawal of CCL20. (Representative data from 1 of 2 experiments is shown.).
Article Snippet: The primary antibodies utilized were anti-mouse B220 (clone-RA3-6B2, BD Biosciences, San Jose, CA), anti-mouse CD3 (Clone-SP7, Abcam, Cambridge, MA), anti-mouse F4/80 (clone-A3-1, AbD Serotec US, Raleigh, NC), anti-mouse FoxP3, (clone- FJK-16, eBioscience, San Diego, CA), anti-human CD163 (clone-10D6, Vector Laboratories Burlingame, CA), anti-human CCR6 (clone- 53103, R&D Systems, Minneapolis, MN),
Techniques: Enzyme-linked Immunosorbent Assay, Expressing, Western Blot, Immunofluorescence, Staining
Journal: PLoS ONE
Article Title: CCR6, the Sole Receptor for the Chemokine CCL20, Promotes Spontaneous Intestinal Tumorigenesis
doi: 10.1371/journal.pone.0097566
Figure Lengend Snippet: (A) Proliferation of MC38 cells after 24 and 48 hours of exposure to CCL20 at concentrations of 10 and 50 ng/ml, IL-6, or serum-free media as measured by the MTT assay is shown. (Representative data from 1 of 2 experiments is shown.) (B) Proliferation of HT29 (left) and Hct116 (right) cells after 24 and 48 hours of exposure to CCL20 at concentrations of 10 and 50 ng/ml. (Representative data from 1 of 2 experiments is shown.).
Article Snippet: The primary antibodies utilized were anti-mouse B220 (clone-RA3-6B2, BD Biosciences, San Jose, CA), anti-mouse CD3 (Clone-SP7, Abcam, Cambridge, MA), anti-mouse F4/80 (clone-A3-1, AbD Serotec US, Raleigh, NC), anti-mouse FoxP3, (clone- FJK-16, eBioscience, San Diego, CA), anti-human CD163 (clone-10D6, Vector Laboratories Burlingame, CA), anti-human CCR6 (clone- 53103, R&D Systems, Minneapolis, MN),
Techniques: MTT Assay
Journal: PLoS ONE
Article Title: CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues
doi: 10.1371/journal.pone.0066286
Figure Lengend Snippet: Fifty IVD tissue samples (Group P, n = 20 and Group E, n = 30) from disc degeneration patients and 3 from scoliosis patients were analyzed. Representative results from each group are shown. No distinct CCL20 expression was detected in the control (a). (b) and (c) represent the CCL20 expression analysis of the protrusion and extrusion groups, respectively. Inflammatory reactions on the edges of extruded IVD tissues are shown in (d). The magnifications of the positive cells were shown in the frame of the top right corner of (b), (c) and (d), respectively. (e) and (f) represent the isotype control of (b) and (c), respectively. Magnification, 400x; scale bars, 20 µm. Image-Pro Plus software was used to perform a quantitative analysis of the IHC results. Compared to the normal control, the expression levels of CCL20, shown as the mean densities of the positive cells, were significantly increased in the patient groups (B, *, P<0.01, significantly different from the control, *△, P<0.01, significantly different from Group E).
Article Snippet: Endogenous peroxidases in the sections were blocked with 3% hydrogen peroxide, and antigen retrieval was performed by microwaving the sections in EDTA (1∶50, ZSGB-Bio, China) at 95°C for 15 min. After blocking the nonspecific proteins with 20% goat serum (ZSGB-Bio, China),
Techniques: Expressing, Control, Software
Journal: PLoS ONE
Article Title: CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues
doi: 10.1371/journal.pone.0066286
Figure Lengend Snippet: Eight IVD tissue samples from disc degeneration patients were used as the primary cultures. NP cells were stimulated with the indicated concentrations of (a) IL-17A or (b) TNF-α for 48 hours. The cells were treated with the optimal concentrations of (c) IL-17A, TNF-α or both for 0, 24, 48 and 72 hours. The cell-free supernatants were harvested and the expression levels of CCL20 protein were quantified by ELISA. The data are representative of at least three separate experiments, performed in duplicate, and the mean protein levels and standard deviations (SD) are shown. Significant differences were detected by a least significance difference analysis (LSD) (P<0.05). There was statistically significant differences between each concentration of IL-17 when compared to the control; however, statistical significance was verified only for TNF-α concentrations higher than 10 ng/ml (IL-17 treatment: *, P<0.01, vs. control; +, P<0.001, vs. 10 ng/ml; # , p<0.05, vs. 1000 ng/ml; TNF-α treatment: *, p<0.001, vs. control; +, p<0.001, vs. 10 ng/ml).
Article Snippet: Endogenous peroxidases in the sections were blocked with 3% hydrogen peroxide, and antigen retrieval was performed by microwaving the sections in EDTA (1∶50, ZSGB-Bio, China) at 95°C for 15 min. After blocking the nonspecific proteins with 20% goat serum (ZSGB-Bio, China),
Techniques: Expressing, Enzyme-linked Immunosorbent Assay, Concentration Assay, Control
Journal: PLoS ONE
Article Title: CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues
doi: 10.1371/journal.pone.0066286
Figure Lengend Snippet: Eight IVD tissue samples from disc degeneration patients were used as the primary cultures. The cells were treated with the indicated concentrations of (a) IL-17A or (b)TNF-α for 48 hours. The expression levels of CCL20 mRNA were detected and the CCL20 transcripts were quantified by real-time RT-PCR analyses in all experiments. The data are representative of at least two separate experiments, performed in duplicate, and the mean increases in the mRNA expression were recorded, after which we evaluated the standard deviations (SD). Significant differences were detected by a least significance difference analysis (LSD) (P<0.05). The results correspond with the findings obtained in the ELISA tests. (IL-17 treatment: *, P<0.001, vs. control; +, P<0.05, vs. 10 ng/ml; # , p<0.01, vs. 1000 ng/ml; TNF-α treatment: *, p<0.001, vs. control; +, p<0.01, vs. 10 ng/ml).
Article Snippet: Endogenous peroxidases in the sections were blocked with 3% hydrogen peroxide, and antigen retrieval was performed by microwaving the sections in EDTA (1∶50, ZSGB-Bio, China) at 95°C for 15 min. After blocking the nonspecific proteins with 20% goat serum (ZSGB-Bio, China),
Techniques: Expressing, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Control
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing.
doi: 10.4049/jimmunol.176.11.6512
Figure Lengend Snippet: FIGURE 1. CCL20 processing by Cath-D and Cath-B. A, Time course of CCL20 processing by Cath-D and Cath-B. CCL20 (5 M) was incubated with 50 ng of Cath-D or Cath-B at 37°C for the indicated times in buffer I (pH 4.0) or buffer II (pH 6.8), respectively. Pep- statin A (2 M) or CA-074 (5 M) were used as inhib- itors for Cath-D and Cath-B, respectively (I). The cleav- age products were separated by SDS-PAGE and stained with Coomassie blue. B, Reverse phase-HPLC profile of the cleavage products of CCL20 after Cath-D and Cath-B processing. C, CCL20 cleavage sites for Cath-D and Cath-B. The positions of the amino acids located at the cleavage sites are indicated.
Article Snippet:
Techniques: Incubation, Inhibition, SDS Page, Staining
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing.
doi: 10.4049/jimmunol.176.11.6512
Figure Lengend Snippet: FIGURE 4. Expression of CCL20 in melanoma cell lines and human malignant melanoma. A, RT-PCR analysis of CCL20 and G3PDH expres- sion in melanoma cell lines A375, A2058, and SK-MEL-2. Positive control RT-PCR products were obtained from primary keratinocytes (Prim. Ker- atin.), human keratinocyte cell line (NCTC 2544), and Caco-2 cells. A 100-base DNA ladder (ladder) and a negative control (no cDNA; control ) are shown. B, Localization of CCL20 transcripts in human malignant melanoma by in situ hybridization. Hybridization signals of antisense CCL20 riboprobes are identified in keratinocytes and melanoma cells. No signals were detected in serial sections hybridized with the sense probe.
Article Snippet:
Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Positive Control, Negative Control, Control, In Situ Hybridization, Hybridization
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing.
doi: 10.4049/jimmunol.176.11.6512
Figure Lengend Snippet: FIGURE 7. Cleavage of CCL20 by melanoma cell lines. A, Processing of CCL20 by membranes of A375 (1), A2058 (2), and SK-MEL-2 (3) cells. CCL20 (5 M) was incubated for 4 h at 37°C with membrane equivalents of 3 105 cells in 50 mM sodium citrate, 50 mM NaCl (pH 4.0), and pepstatin A as indicated. The cleavage products were separated by SDS-PAGE and stained with Coomassie blue. The molecular masses of intact CCL201–70 and CCL201–55 after Cath-D cleavage are 8025 and 6224 Da, respectively (arrows). B, Processing of CCL20 by purified Cath-B (left panel) or Cath-D (middle panel) for 1.5 h or membranes of SK-MEL-2 cells (right panel) for 4 h at pH 4.0 in presence of CA-074 and pepstatin A as indicated. The molecular masses of intact CCL201–70, CCL201–66 after Cath-B cleavage and CCL201–55 after Cath-D cleavage are 8025, 7552, and 6224 Da, respectively (arrows). C, As in A but incubation was with PBS containing 4 mM EDTA, 2 mM L-cysteine, 0.1% Triton X-100 (pH 6.8). D, Processing of CCL20 by conditioned medium of SK-MEL-2 cells. Conditioned medium was concentrated (2.5) and incubated with CCL20 (5 M) at pH 4.0 for the indicated times and in the presence of pepstatin A (left panel). Coomassie blue staining of CCL20 incubated for 8 h with purified Cath-D or conditioned medium is shown in the middle panel. The right panel shows migration in response to increasing concentrations of CCL20 after incubation for 8 h in conditioned medium with or without pepstatin A. Results are expressed as means SD of the numbers of cells observed per five high-power fields. A representative experiment of three is shown. IB, Immunoblotting; Cond. medium, conditioned medium.
Article Snippet:
Techniques: Incubation, Membrane, SDS Page, Staining, Migration, Western Blot